Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia-Reference-Cited by-同舟云学术

Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia

Published:2018-02-01 Issue:3 Volume:51 Page:1702550
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Guglielmetti Lorenzo^ORCID,Barkane Linda,Le Dû Damien,Marigot-Outtandy Dhiba,Robert Jérôme,Veziris Nicolas,Yazdanpanah Yazdan,Kuksa Liga,Caumes Eric,Fréchet-Jachym Mathilde

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Bastos ML , Lan Z , Menzies D . An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J 2017; 49: 1600803.

2. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

3. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis;Skripconoka;Eur Respir J,2012

4. Bedaquiline plus delamanid for XDR tuberculosis;Lachatre;Lancet Infect Dis,2016

5. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid;Scientific Reports;2024-07-29

2. Real-life use of delamanid: results from the European post-authorisation safety study;IJTLD OPEN;2024-06-01

3. Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-05

4. QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis;Antibiot Khimioter = Antibiotics and Chemotherapy;2024-03-27

5. Impact of Prior TB Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for MDR/RR-TB;Clinical Infectious Diseases;2023-11-14